Strange IndiaStrange India

We agree with André et al. (Nature 626, 26–29; 2024) that personalized cancer treatment is crucial, and that molecular testing has a part to play. But disease specificity remains an important determinant of high-quality cancer care.

Competing Interests

Table of Contents

The authors declare no competing interests.

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *